<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36042292</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1745-7254</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Acta pharmacologica Sinica</Title><ISOAbbreviation>Acta Pharmacol Sin</ISOAbbreviation></Journal><ArticleTitle>BL-918, a small-molecule activator of ULK1, induces cytoprotective autophagy for amyotrophic lateral sclerosis therapy.</ArticleTitle><Pagination><StartPage>524</StartPage><EndPage>537</EndPage><MedlinePgn>524-537</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41401-022-00972-w</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is one of the most common fatal neurodegenerative diseases in adults. ALS pathogenesis is associated with toxic SOD1 aggregates generated by mutant SOD1. Since autophagy is responsible for the clearance of toxic protein aggregates including SOD1 aggregates, autophagy induction has been considered as a potential strategy for treating ALS. Autophagic signaling is initiated by unc-51 like autophagy activating kinase 1 (ULK1) complex. We previously identified that BL-918 as a specific ULK1 activator, which exerted cytoprotective effect against Parkinson's disease in vitro and in vivo. In this study we investigated whether BL-918 exerted a therapeutic effect against ALS, and characterized its pharmacokinetic profile in rats. In hSOD<sup>G93A</sup>-NSC34 cells, treatment with BL-918 (5, 10&#x2009;&#x3bc;M) dose-dependently induced ULK1-dependent autophagy, and eliminated toxic SOD1 aggregates. In SOD<sup>G93A</sup> mice, administration of BL-918 (40, 80&#x2009;mg/kg, b.i.d., i.g.) dose-dependently prolonged lifespan and improved the motor function, and enhanced the clearance of SOD1 aggregates in spinal cord and cerebral cortex through inducing autophagy. In the pharmacokinetic study conducted in rats, we found BL-918 and its 2 metabolites (M8 and M10) present in spinal cord and brain; after intragastric and intravenous administration, BL-918 reached the highest blood concentration compared to M8 and M10. Collectively, ULK1 activator BL-918 displays a therapeutic potential on ALS through inducing cytoprotective autophagy. This study provides a further clue for autophagic dysfunction in ALS pathogenesis.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhu</LastName><ForeName>Shi-Ou</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Guo</LastName><ForeName>Yu-Lin</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, 510632, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Engineering Research Center of Chinese Medicine &amp; Disease Susceptibility, Jinan University, Guangzhou, 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tu</LastName><ForeName>Long-Fang</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, 510632, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Engineering Research Center of Chinese Medicine &amp; Disease Susceptibility, Jinan University, Guangzhou, 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhen</LastName><ForeName>Yong-Qi</ForeName><Initials>YQ</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Rong-Yan</ForeName><Initials>RY</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ou-Yang</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China. ouyangliang@scu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurihara</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, 510632, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Engineering Research Center of Chinese Medicine &amp; Disease Susceptibility, Jinan University, Guangzhou, 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Rong-Rong</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, 510632, China. rongronghe@jnu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Engineering Research Center of Chinese Medicine &amp; Disease Susceptibility, Jinan University, Guangzhou, 510632, China. rongronghe@jnu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China. liubo2400@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Acta Pharmacol Sin</MedlineTA><NlmUniqueID>100956087</NlmUniqueID><ISSNLinking>1671-4083</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C586255">ULK1 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D000071189">Autophagy-Related Protein-1 Homolog</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071189" MajorTopicYN="N">Autophagy-Related Protein-1 Homolog</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BL-918</Keyword><Keyword MajorTopicYN="N">ULK1</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">cytoprotective autophagy</Keyword><Keyword MajorTopicYN="N">pharmacokinetic</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>23</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36042292</ArticleId><ArticleId IdType="pmc">PMC9958028</ArticleId><ArticleId IdType="doi">10.1038/s41401-022-00972-w</ArticleId><ArticleId IdType="pii">10.1038/s41401-022-00972-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tandan R, Bradley WG. Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management. Ann Neurol. 1985;18:271&#x2013;80. doi: 10.1002/ana.410180302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410180302</ArticleId><ArticleId IdType="pubmed">4051456</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;98. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdmanis PN, Rouleau GA. Genetics of familial amyotrophic lateral sclerosis. Neurology. 2008;70:144&#x2013;52. doi: 10.1212/01.wnl.0000296811.19811.db.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000296811.19811.db</ArticleId><ArticleId IdType="pubmed">18180444</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, van den Berg LH, Veldink J. Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat Rev Neurol. 2017;13:96&#x2013;104. doi: 10.1038/nrneurol.2016.182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.182</ArticleId><ArticleId IdType="pubmed">27982040</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu LF, Zhang TZ, Zhou YF, Zhou QQ, Gong HB, Liang L, et al. GPX4 deficiency-dependent phospholipid peroxidation drives motor deficits of ALS. J Adv Res. 2022; 10.1016/j.jare.2022.02.016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9811330</ArticleId><ArticleId IdType="pubmed">36585109</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, Ohama E, et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 1998;281:1851&#x2013;4. doi: 10.1126/science.281.5384.1851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.281.5384.1851</ArticleId><ArticleId IdType="pubmed">9743498</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay M, Valentine JS. Aggregation of copper-zinc superoxide dismutase in familial and sporadic ALS. Antioxid Redox Signal. 2009;11:1603&#x2013;14. doi: 10.1089/ars.2009.2536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2536</ArticleId><ArticleId IdType="pmc">PMC2842589</ArticleId><ArticleId IdType="pubmed">19271992</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur SJ, McKeown SR, Rashid S. Mutant SOD1 mediated pathogenesis of amyotrophic lateral sclerosis. Gene. 2016;577:109&#x2013;18. doi: 10.1016/j.gene.2015.11.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.11.049</ArticleId><ArticleId IdType="pubmed">26657039</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal Canto MC, Gurney ME. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu, Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS) Brain Res. 1995;676:25&#x2013;40. doi: 10.1016/0006-8993(95)00063-V.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(95)00063-V</ArticleId><ArticleId IdType="pubmed">7796176</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda E, Br&#xe4;nnstr&#xf6;m T, Andersen PM, Marklund SL. Low autophagy capacity implicated in motor system vulnerability to mutant superoxide dismutase. Acta Neuropathol Commun. 2016;4:6. doi: 10.1186/s40478-016-0274-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0274-y</ArticleId><ArticleId IdType="pmc">PMC4727314</ArticleId><ArticleId IdType="pubmed">26810478</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P, Robberecht W, Van Den Bosch L. Modelling amyotrophic lateral sclerosis: progress and possibilities. Dis Model Mech. 2017;10:537&#x2013;49. doi: 10.1242/dmm.029058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.029058</ArticleId><ArticleId IdType="pmc">PMC5451175</ArticleId><ArticleId IdType="pubmed">28468939</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendotti C, Marino M, Cheroni C, Fontana E, Crippa V, Poletti A, et al. Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: implication for protein aggregation and immune response. Prog Neurobiol. 2012; 97:101&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">22033150</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci. 2013;14:248&#x2013;64. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Wang G, Wang Z, Wang G, Huang J, Liu B. Repurposing small-molecule drugs for modulating toxic protein aggregates in neurodegenerative diseases. Drug Discov Today. 2022;27:1994&#x2013;2007. doi: 10.1016/j.drudis.2022.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2022.04.003</ArticleId><ArticleId IdType="pubmed">35395400</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijholt DA, De Kimpe L, Elfrink HL, Hoozemans JJ, Scheper W. Removing protein aggregates: the role of proteolysis in neurodegeneration. Curr Med Chem. 2011;18:2459&#x2013;76. doi: 10.2174/092986711795843236.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986711795843236</ArticleId><ArticleId IdType="pubmed">21568912</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev. 2010;90:1383&#x2013;435. doi: 10.1152/physrev.00030.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00030.2009</ArticleId><ArticleId IdType="pubmed">20959619</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13:132&#x2013;41. doi: 10.1038/ncb2152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2152</ArticleId><ArticleId IdType="pmc">PMC3987946</ArticleId><ArticleId IdType="pubmed">21258367</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara T, Takamura A, Kishi C, Iemura S, Natsume T, Guan JL, et al. FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J Cell Biol. 2008;181:497&#x2013;510. doi: 10.1083/jcb.200712064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200712064</ArticleId><ArticleId IdType="pmc">PMC2364687</ArticleId><ArticleId IdType="pubmed">18443221</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell. 2009;20:1981&#x2013;91. doi: 10.1091/mbc.e08-12-1248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e08-12-1248</ArticleId><ArticleId IdType="pmc">PMC2663915</ArticleId><ArticleId IdType="pubmed">19211835</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosokawa N, Sasaki T, Iemura S, Natsume T, Hara T, Mizushima N. Atg101, a novel mammalian autophagy protein interacting with Atg13. Autophagy. 2009;5:973&#x2013;9. doi: 10.4161/auto.5.7.9296.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.5.7.9296</ArticleId><ArticleId IdType="pubmed">19597335</ArticleId></ArticleIdList></Reference><Reference><Citation>Nah J, Yuan J, Jung YK. Autophagy in neurodegenerative diseases: from mechanism to therapeutic approach. Mol Cells. 2015;38:381&#x2013;9. doi: 10.14348/molcells.2015.0034.</Citation><ArticleIdList><ArticleId IdType="doi">10.14348/molcells.2015.0034</ArticleId><ArticleId IdType="pmc">PMC4443278</ArticleId><ArticleId IdType="pubmed">25896254</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassif M, Hetz C. Targeting autophagy in ALS: a complex mission. Autophagy. 2011;7:450&#x2013;3. doi: 10.4161/auto.7.4.14700.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.7.4.14700</ArticleId><ArticleId IdType="pubmed">21252621</ArticleId></ArticleIdList></Reference><Reference><Citation>Djajadikerta A, Keshri S, Pavel M, Prestil R, Ryan L, Rubinsztein DC. Autophagy induction as a therapeutic strategy for neurodegenerative diseases. J Mol Biol. 2020;432:2799&#x2013;821. doi: 10.1016/j.jmb.2019.12.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2019.12.035</ArticleId><ArticleId IdType="pubmed">31887286</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Mu Y, Jiang Y, Song R, Yi J, Zhou J, et al. Inhibition of p70 S6 kinase activity by A77 1726 induces autophagy and enhances the degradation of superoxide dismutase 1 (SOD1) protein aggregates. Cell Death Dis. 2018;9:1&#x2013;16.. doi: 10.1038/s41419-018-0441-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0441-0</ArticleId><ArticleId IdType="pmc">PMC5851998</ArticleId><ArticleId IdType="pubmed">29540819</ArticleId></ArticleIdList></Reference><Reference><Citation>Granatiero V, Sayles NM, Savino AM, Konrad C, Kharas MG, Kawamata H, et al. Modulation of the IGF1R-MTOR pathway attenuates motor neuron toxicity of human ALS SOD1G93A astrocytes. Autophagy. 2021;17:4029&#x2013;42. doi: 10.1080/15548627.2021.1899682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1899682</ArticleId><ArticleId IdType="pmc">PMC8726657</ArticleId><ArticleId IdType="pubmed">33749521</ArticleId></ArticleIdList></Reference><Reference><Citation>Galluzzi L, Bravo-San Pedro JM, Levine B, Green DR, Kroemer G. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat Rev Drug Discov. 2017;16:487&#x2013;511. doi: 10.1038/nrd.2017.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2017.22</ArticleId><ArticleId IdType="pmc">PMC5713640</ArticleId><ArticleId IdType="pubmed">28529316</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang L, Zhang L, Zhang S, Yao D, Zhao Y, Wang G, et al. Small-molecule activator of UNC-51-like kinase 1 (ULK1) that induces cytoprotective autophagy for Parkinson&#x2019;s disease treatment. J Med Chem. 2018;61:2776&#x2013;92. doi: 10.1021/acs.jmedchem.7b01575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.7b01575</ArticleId><ArticleId IdType="pubmed">29561612</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng J, Pan J, Mo J, Peng Y. MPO/HOCl facilitates apoptosis and ferroptosis in the SOD1G93A motor neuron of amyotrophic lateral sclerosis. Oxid Med Cell Longev. 2022;2022:8217663. doi: 10.1155/2022/8217663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/8217663</ArticleId><ArticleId IdType="pmc">PMC8845144</ArticleId><ArticleId IdType="pubmed">35178161</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM, Prudencio M, Winkler DD, Hart PJ, Borchelt DR. Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proc Natl Acad Sci USA. 2009;106:7774&#x2013;9. doi: 10.1073/pnas.0902505106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0902505106</ArticleId><ArticleId IdType="pmc">PMC2675570</ArticleId><ArticleId IdType="pubmed">19416874</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nther R, Suhr M, Koch JC, B&#xe4;hr M, Lingor P, T&#xf6;nges L. Clinical testing and spinal cord removal in a mouse model for amyotrophic lateral sclerosis (ALS) J Vis Exp. 2012;61:3936.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3415170</ArticleId><ArticleId IdType="pubmed">22453893</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Li L, Chen S, Yang D, Wang Y, Zhang X, et al. Rapamycin treatment augments motor neuron degeneration in SOD1 G93A mouse model of amyotrophic lateral sclerosis. Autophagy. 2011;7:412&#x2013;25. doi: 10.4161/auto.7.4.14541.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.7.4.14541</ArticleId><ArticleId IdType="pubmed">21193837</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucocq JM, Hacker C. Cutting a fine figure: On the use of thin sections in electron microscopy to quantify autophagy. Autophagy. 2013;9:1443&#x2013;8. doi: 10.4161/auto.25570.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.25570</ArticleId><ArticleId IdType="pubmed">23881027</ArticleId></ArticleIdList></Reference><Reference><Citation>Eskelinen EL, Reggiori F, Baba M, Kov&#xe1;cs AL, Seglen PO. Seeing is believing: the impact of electron microscopy on autophagy research. Autophagy. 2011;7:935&#x2013;56. doi: 10.4161/auto.7.9.15760.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.7.9.15760</ArticleId><ArticleId IdType="pubmed">21566462</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1. Autophagy. 2021;17:1&#x2013;382. doi: 10.1080/15548627.2020.1797280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2020.1797280</ArticleId><ArticleId IdType="pmc">PMC7996087</ArticleId><ArticleId IdType="pubmed">33634751</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovejoy DB, Guillemin GJ. The potential for transition metal-mediated neurodegeneration in amyotrophic lateral sclerosis. Front Aging Neurosci. 2014;6:173. doi: 10.3389/fnagi.2014.00173.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2014.00173</ArticleId><ArticleId IdType="pmc">PMC4107949</ArticleId><ArticleId IdType="pubmed">25100994</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S, Semmler S, Broom HR, Destroismaisons L, Legroux L, Arbour N, et al. ALS-linked misfolded SOD1 species have divergent impacts on mitochondria. Acta Neuropathol Commun. 2016;4:43. doi: 10.1186/s40478-016-0313-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0313-8</ArticleId><ArticleId IdType="pmc">PMC4847257</ArticleId><ArticleId IdType="pubmed">27121871</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo TG, Yoon MH, Kang SM, Park S, Cho JH, Hwang YJ, et al. Novel chemical inhibitor against SOD1 misfolding and aggregation protects neuron-loss and ameliorates disease symptoms in ALS mouse model. Commun Biol. 2021;4:1397. doi: 10.1038/s42003-021-02862-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02862-z</ArticleId><ArticleId IdType="pmc">PMC8674338</ArticleId><ArticleId IdType="pubmed">34912047</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CS, Tao Y, Xu F, Ng WWY, Jia Y, Yuan H, et al. A robust correlation analysis framework for imbalanced and dichotomous data with uncertainty. Inf Sci. 2019;470:58&#x2013;77. doi: 10.1016/j.ins.2018.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ins.2018.08.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L, Chen S, Du F, Li S, Zhao L, Wang X. Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK. Proc Natl Acad Sci USA. 2011;108:4788&#x2013;93. doi: 10.1073/pnas.1100844108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1100844108</ArticleId><ArticleId IdType="pmc">PMC3064373</ArticleId><ArticleId IdType="pubmed">21383122</ArticleId></ArticleIdList></Reference><Reference><Citation>Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science. 2011;331:456&#x2013;61. doi: 10.1126/science.1196371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1196371</ArticleId><ArticleId IdType="pmc">PMC3030664</ArticleId><ArticleId IdType="pubmed">21205641</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang GG, Abraham RT. Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J Biol Chem. 2005;280:25485&#x2013;90. doi: 10.1074/jbc.M501707200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M501707200</ArticleId><ArticleId IdType="pubmed">15899889</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Han X, Ou D, Liu T, Li Z, Jiang G, et al. Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy. Appl Microbiol Biotechnol. 2020;104:575&#x2013;87. doi: 10.1007/s00253-019-10257-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-019-10257-8</ArticleId><ArticleId IdType="pubmed">31832711</ArticleId></ArticleIdList></Reference><Reference><Citation>Querfurth H, Lee HK. Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration. Mol Neurodegener. 2021;16:44. doi: 10.1186/s13024-021-00428-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00428-5</ArticleId><ArticleId IdType="pmc">PMC8252260</ArticleId><ArticleId IdType="pubmed">34215308</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueiredo VC, Markworth JF, Cameron-Smith D. Considerations on mTOR regulation at serine 2448: implications for muscle metabolism studies. Cell Mol Life Sci. 2017;74:2537&#x2013;45. doi: 10.1007/s00018-017-2481-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-017-2481-5</ArticleId><ArticleId IdType="pubmed">28220207</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Ouyang L, Guo Y, Zhang J, Liu B. UNC-51-like kinase 1: from an autophagic initiator to multifunctional drug target. J Med Chem. 2018;61:6491&#x2013;500. doi: 10.1021/acs.jmedchem.7b01684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.7b01684</ArticleId><ArticleId IdType="pubmed">29509411</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011;18:571&#x2013;80. doi: 10.1038/cdd.2010.191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2010.191</ArticleId><ArticleId IdType="pmc">PMC3131912</ArticleId><ArticleId IdType="pubmed">21311563</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402:672&#x2013;6. doi: 10.1038/45257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/45257</ArticleId><ArticleId IdType="pubmed">10604474</ArticleId></ArticleIdList></Reference><Reference><Citation>Weydt P, Hong SY, Kliot M, M&#xf6;ller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. NeuroReport. 2003;14:1051.</Citation><ArticleIdList><ArticleId IdType="pubmed">12802201</ArticleId></ArticleIdList></Reference><Reference><Citation>Narasimhan K. Quantifying motor neuron loss in ALS. Nat Neurosci. 2006;9:304&#x2013;304. doi: 10.1038/nn0306-304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn0306-304</ArticleId><ArticleId IdType="pubmed">16498424</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;5. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin A, Perera ND, Beart PM, Turner BJ, Shabanpoor F. Amyotrophic lateral sclerosis and autophagy: dysfunction and therapeutic targeting. Cells. 2020;9:2413. doi: 10.3390/cells9112413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9112413</ArticleId><ArticleId IdType="pmc">PMC7694295</ArticleId><ArticleId IdType="pubmed">33158177</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang H, Zhang J, Lin C, Zhang L, Liu B, Ouyang L. Targeting autophagy-related protein kinases for potential therapeutic purpose. Acta Pharm Sin B. 2020;10:569&#x2013;81. doi: 10.1016/j.apsb.2019.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2019.10.003</ArticleId><ArticleId IdType="pmc">PMC7161711</ArticleId><ArticleId IdType="pubmed">32322463</ArticleId></ArticleIdList></Reference><Reference><Citation>Fornai F, Longone P, Cafaro L, Kastsiuchenka O, Ferrucci M, Manca ML, et al. Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 2008;105:2052&#x2013;7. doi: 10.1073/pnas.0708022105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0708022105</ArticleId><ArticleId IdType="pmc">PMC2538879</ArticleId><ArticleId IdType="pubmed">18250315</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JJ, Zhou QM, Chen S, Le WD. Repurposing carbamazepine for the treatment of amyotrophic lateral sclerosis in SOD1-G93A mouse model. CNS Neurosci Ther. 2018;24:1163&#x2013;74. doi: 10.1111/cns.12855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12855</ArticleId><ArticleId IdType="pmc">PMC6489874</ArticleId><ArticleId IdType="pubmed">29656576</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, Liang C, Swaminathan K, Herrlinger S, Lai F, Shiekhattar R, et al. A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci Adv. 2016;2:1&#x2013;18. doi: 10.1126/sciadv.1601167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1601167</ArticleId><ArticleId IdType="pmc">PMC5010369</ArticleId><ArticleId IdType="pubmed">27617292</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan PM, Zhou X, Robins AM, Paushter DH, Kim D, Smolka MB, et al. The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway. Acta Neuropathol Commun. 2016;4:51. doi: 10.1186/s40478-016-0324-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0324-5</ArticleId><ArticleId IdType="pmc">PMC4870812</ArticleId><ArticleId IdType="pubmed">27193190</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckers J, Tharkeshwar AK, Van Damme P. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels. Autophagy. 2021;17:3306&#x2013;22. doi: 10.1080/15548627.2021.1872189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1872189</ArticleId><ArticleId IdType="pmc">PMC8632097</ArticleId><ArticleId IdType="pubmed">33632058</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding O, Evans CS, Ye J, Cheung J, Maniatis T, Holzbaur ELF. ALS- and FTD-associated missense mutations in TBK1 differentially disrupt mitophagy. Proc Natl Acad Sci USA. 2021;118:e2025053118. doi: 10.1073/pnas.2025053118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2025053118</ArticleId><ArticleId IdType="pmc">PMC8214690</ArticleId><ArticleId IdType="pubmed">34099552</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>